Stratos Wealth Partners’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,907
| Closed | -$203K | – | 1516 |
|
|
2024
Q3 | $203K | Buy |
+2,907
| New | +$203K | ﹤0.01% | 1337 |
|
|
2024
Q1 | – | Sell |
-3,157
| Closed | -$208K | – | 1440 |
|
|
2023
Q4 | $208K | Buy |
+3,157
| New | +$208K | ﹤0.01% | 1258 |
|
|
2023
Q1 | – | Sell |
-3,263
| Closed | -$207K | – | 1193 |
|
|
2022
Q4 | $207K | Buy |
+3,263
| New | +$207K | 0.01% | 1031 |
|
|
2022
Q3 | – | Sell |
-3,848
| Closed | -$222K | – | 1203 |
|
|
2022
Q2 | $222K | Sell |
3,848
-108
| -3% | -$6.23K | 0.01% | 1047 |
|
|
2022
Q1 | $245K | Sell |
3,956
-369
| -9% | -$22.9K | 0.01% | 1075 |
|
|
2021
Q4 | $308K | Sell |
4,325
-356
| -8% | -$25.4K | 0.01% | 990 |
|
|
2021
Q3 | $350K | Sell |
4,681
-197
| -4% | -$14.7K | 0.01% | 895 |
|
|
2021
Q2 | $377K | Sell |
4,878
-600
| -11% | -$46.4K | 0.01% | 876 |
|
|
2021
Q1 | $404K | Buy |
5,478
+605
| +12% | +$44.6K | 0.01% | 779 |
|
|
2020
Q4 | $342K | Buy |
4,873
+567
| +13% | +$39.8K | 0.01% | 806 |
|
|
2020
Q3 | $244K | Hold |
4,306
| – | – | 0.01% | 856 |
|
|
2020
Q2 | $251K | Sell |
4,306
-228
| -5% | -$13.3K | 0.01% | 825 |
|
|
2020
Q1 | $211K | Sell |
4,534
-325
| -7% | -$15.1K | 0.01% | 801 |
|
|
2019
Q4 | $271K | Buy |
4,859
+56
| +1% | +$3.12K | 0.01% | 788 |
|
|
2019
Q3 | $228K | Buy |
4,803
+22
| +0.5% | +$1.04K | 0.01% | 833 |
|
|
2019
Q2 | $256K | Sell |
4,781
-155
| -3% | -$8.3K | 0.01% | 788 |
|
|
2019
Q1 | $272K | Hold |
4,936
| – | – | 0.01% | 754 |
|
|
2018
Q4 | $232K | Buy |
4,936
+4,027
| +443% | +$189K | 0.01% | 752 |
|
|
2018
Q3 | $54K | Buy |
+909
| New | +$54K | ﹤0.01% | 1418 |
|
|
2018
Q2 | – | Sell |
-934
| Closed | -$46K | – | 2099 |
|
|
2018
Q1 | $46K | Sell |
934
-75
| -7% | -$3.69K | ﹤0.01% | 1623 |
|
|
2017
Q4 | $48K | Buy |
+1,009
| New | +$48K | ﹤0.01% | 1531 |
|